Galaxy Pharma (Pvt) Limited

Welcome

Chairman Message

About Us

Pharma Products

IVF-C (HCG)

IVF-M (HMG)

Follimon (u FSH)

Follitrope (rec FSH)

Aromek

Utrogestan

Propess

Prelox

Glasterone

Pycnoforte

Ova-Surge

IUI Products

Galaxy IUI Kit

Galaxy IUI Catheter

Sydeny IVF Sperm Media

Galaxy Partners

Distribution Network

Contact Us

Innovative & Niche Medication for Healthy Families

IVF - M (Human Menopausal Gonadotropin)
  • Product Name

    IVF-M
  • Composition

  • Each vial contains 75 IU or 150 IU of hMG (human menopausal gonadotropin), having equal quatities of FSH (follicle stimualting hormone) and LH (luteinizing hormone).
  • Indication

  • For stimulation of the development of multiple follicles (superovulation) in women undergoing Assisted Reproductive Techniques (ART)

    Due to ovulatory disorder – Ovulation induction

    Male hypogonadotropic hypogonadism
    Dosage and Administration
  • 1. For stimulation of the development of multiple follicles (superovulation) in women undergoing Assisted Reproductive Techniques (ART) / Due to ovulatory disorder – Ovulation induction
  • - Inject intramuscularly 75 IU a day for 7 ~ 12 days and administer 5,000 ~ 10,000 IU hCG (IVF-C) one day after the last treatment of IVF-M.
    - A cycle should be limited to 12 days.
    - Treatment continues until estrogen activity of patient equals to or goes higher than that of healthy women.
    - If ovary abnormally enlarges at the end of treatment, do not administer hCG to avoid ovarian hyperstimulation syndrome (OHSS).
    - If it is evident that ovulation occurs but pregnancy doesn’t ensue, repeat this regiment and administer 5,000 ~ 10,000 IU hCG (IVF-C) one day after the last injection of IVF-M. After at least twice repetition of this regimen, increase the dose to 150 IU a day and repeat this cycle more than twice. Doses higher than 150 IU are not recommended.

    2. Male hypogonadotropic hypogonadism


    - Inject intramuscularly 75 IU thrice a week with concomitant administration of 2,000 IU hCG (IVF-C) twice a week for at least 4 months.
    - Before combination therapy with IVF-M and hCG (IVF-C), a pre-treatment of 2,000 ~ 5,000 IU hCG (IVF-C) thrice a week for 4 ~ 6 months is required to ensure full development of secondary sexual characters and reach normal range of testosterone.
    - If spermatogenesis is not evident at the end of treatment, inject 75 ~ 150 IU thrice a week with concomitant administration of 2,000 IU hCG (IVF-C) twice a week.
    How Supplied

  • 75 IU/vial× 1 vial/pack(with solvent)
    150 IU/vial×1, 5 vials/pack(with solvent)
  • Storage Condition

  • Store in the light-resistant place at room temperature (1 ~ 30 ℃)
  • Shelf Life

  • 24 months

  • Copyright: Galaxy Pharma (Pvt) Limited - 2007 - 2010